IMRT Course 2016

Conclusions

IMRT offers opportunities across different sarcomas: Soft tissue sarcomas – improved conformality to PTV, reduced dose to normal tissues, sparing of normal structures (e.g. bone), improved late toxicity? Bone sarcomas: Delivery of optimal dose to PTV with normal tissue sparing (Ewing’s sarcoma) Dose escalation for more radioresistant tumours (primary bone sarcomas, chondrosarcoma, chordoma) PBT/carbon ions will offer advantage for some patients, but not easily accessible to all, so IMRT remains important

44